The Rise and Fall of the Age of Psychopharmacology

Name: The Rise and Fall of the Age of Psychopharmacology
Price: 41.20 USD
Availability: InStock
Rating: 4.4 (17 reviews)

4.4 of 5 Stars: History - The Rise and Fall of the Age of Psychopharmacology

$41.20

Buying Options

Description

Book Synopsis: The Age of Psychopharmacology began with a brilliant rise in the 1950s, when for the first time science entered the study of drugs that affect the brain and mind. But, esteemed historian Edward Shorter argues that there has been a recent fall, as the field has seen its drug offerings impoverished and its diagnoses distorted by the "Diagnostic and Statistical Manual of Mental Disorders." The new drugs, such as Prozac, have been less effective than the old. The new diagnoses, such as "major depression," have strayed increasingly from the real disorders of most patients. Behind this disaster has been the invasion of the field by the pharmaceutical industry. This invasion has paid off commercially but not scientifically: There have been no new classes of psychiatry drugs in the last thirty years. Given that psychiatry's diagnoses and therapeutics have largely failed, the field has greatly declined from earlier days. Based on extensive research discovered in litigation, Shorter provides a historical perspective of change and decline over time, concluding that the story of the psychopharmacology is a story of a public health disaster.

Details

Are you tired of feeling like your mental health is at the mercy of pharmaceutical companies? Look no further than "The Rise and Fall of the Age of Psychopharmacology" by Edward Shorter, a captivating book that sheds light on the decline of the field. Shorter, a renowned historian, reveals how the scientific study of drugs affecting the brain and mind took a wrong turn in recent years. The once-promising field has been infiltrated by the pharmaceutical industry, resulting in impoverished drug offerings and distorted diagnoses.

With this eye-opening book, you'll discover the truth behind the current state of psychopharmacology. Shorter delves into the shortcomings of new drugs like Prozac compared to their predecessors, highlighting how they have been less effective. The field's reliance on the problematic "Diagnostic and Statistical Manual of Mental Disorders" has led to an increasing disconnect from the real disorders patients face. It's time to challenge the status quo and gain a deeper understanding of the pitfalls within the field.

What makes "The Rise and Fall of the Age of Psychopharmacology" truly remarkable is its foundation in extensive research discovered in litigation. Shorter presents a historical perspective that unveils the changes and declines over time, revealing the story of a public health disaster. It's crucial to grasp the magnitude of this issue, and Shorter's expertise ensures that you gain a comprehensive view of the subject matter.

Don't let the pharmaceutical industry dictate your mental health journey any longer. Take control by arming yourself with knowledge from "The Rise and Fall of the Age of Psychopharmacology." Learn how the field has declined and why its diagnoses and therapeutics have largely failed. Grab your copy today and empower yourself to make informed decisions for your mental well-being.

Ready to uncover the truth? Purchase "The Rise and Fall of the Age of Psychopharmacology" now through the following link:

Buy now!

See All Buying Options...

More Details...